Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Climatotherapy At The Dead Sea For Atopic Dermatitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01307150
First received: July 6, 2009
Last updated: March 1, 2011
Last verified: July 2009

July 6, 2009
March 1, 2011
June 2009
November 2009   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01307150 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Climatotherapy At The Dead Sea For Atopic Dermatitis
Evaluation of the Efficacy of Dead Sea Climatotherapy on Atopic Dermatitis Patients.

The purpose of this study is to evaluate the improvement in severity of Atopic Dermatitis and quality of life after 4 weeks of treatment in the Dead Sea.

28 days treatment period, sun exposure and possibly Dead Sea baths after an exact given plan, discontinuation of all local Cortisone preparations, unlimited use of maintenance drags, doctor visit twice a week, continuous checks by the nurse.

Determination of the SCORAD index by the same doctor on arrival and departure. Before and after the treatment, the patient will answer written questionnaires regarding quality of life.

Observational
Observational Model: Case-Crossover
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Atopic Dermatitis patient.

Atopic Dermatitis
Not Provided
Before and after treatment
SCORAD of each patient before and after treatment.
Harari M, Shani J, Seidl V, Hristakieva E. Climatotherapy of atopic dermatitis at the Dead Sea: demographic evaluation and cost-effectiveness. Int J Dermatol. 2000 Jan;39(1):59-69.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
50
December 2009
November 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Minimum age of 18 years old

Exclusion Criteria:

  • Skin type - I
  • Psoriasis patient in addition to Atopic Dermatitis
  • Pregnancy
  • Past malignancy
  • Less then 2 weeks of treatment
Both
18 Years and older
No
Contact: Arik Tzukert, DMD +972-(0)2-6776095 arik@hadassah.org.il
Contact: Hadas Lemberg, PhD +972-(0)2-6777572 1hadas@hadassah.org.il
Israel
 
NCT01307150
SK09409-HMO-CTIL
No
Hasassah Medical Organization IRB, Israel Ministry of Health
Hadassah Medical Organization
Not Provided
Study Chair: Arie Ingber, MD. Hadassa Medical Organization IRB
Hadassah Medical Organization
July 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP